Skip to main content
SpringerLink
Log in
SpringerLink
Log in

A Translational Approach to Novel Medication Development for Protracted Abstinence

  • Chapter
  • First Online:
Behavioral Neurobiology of Alcohol Addiction

Part of the book series: Current Topics in Behavioral Neurosciences ((CTBN,volume 13))

Abstract

Alcohol dependence is a chronic relapsing disorder. Despite significant strides in the development of efficacious behavioral and pharmacological treatments for alcohol dependence, relapse rates remain very high. In this chapter, we review validated animal and human laboratory models for assessing risk of relapse in alcohol dependence and neurobiological treatment targets derived from such models. We suggest a translational approach to evaluate potential pharmacological treatments, using existing medications to validate and refine research paradigms across clinical and pre-clinical domains, with the aim of providing an accelerated framework for medications development in alcohol dependence. Lastly, empirical findings from proof-of-concept human laboratory studies are reviewed as we discuss the importance of selecting human laboratory models with predictive validity for the mechanism of action of the drug undergoing evaluation for efficacy in alcohol dependence.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Addolorato G, Leggio L, Abenavoli L, Gasbarrini G (2005) Neurobiochemical and clinical aspects of craving in alcohol addiction: a review. Addict Behav 30:1209–1224

    PubMed  Google Scholar 

  • Adinoff B, Junghanns K, Kiefer F, Krishnan-Sarin S (2005a) Suppression of the HPA axis stress-response: implications for relapse. Alcohol Clin Exp Res 29:1351–1355

    CAS  PubMed Central  PubMed  Google Scholar 

  • Adinoff B, Krebaum SR, Chandler PA, Ye W, Brown MB, Williams MJ (2005b) Dissection of hypothalamic-pituitary-adrenal axis pathology in 1-month-abstinent alcohol-dependent men, part 1: adrenocortical and pituitary glucocorticoid responsiveness. Alcohol Clin Exp Res 29:517–527

    CAS  PubMed Central  PubMed  Google Scholar 

  • Adinoff B, Risher-Flowers D, De Jong J, Ravitz B, Bone GH, Nutt DJ, Roehrich L, Martin PR, Linnoila M (1991) Disturbances of hypothalamic-pituitary-adrenal axis functioning during ethanol withdrawal in six men. Am J Psychiatry 148:1023–1025

    CAS  PubMed  Google Scholar 

  • Adinoff B, Ruether K, Krebaum S, Iranmanesh A, Williams MJ (2003) Increased salivary cortisol concentrations during chronic alcohol intoxication in a naturalistic clinical sample of men. Alcohol Clin Exp Res 27:1420–1427

    CAS  PubMed  Google Scholar 

  • Alling C, Balldin J, Bokstrom K, Gottfries CG, Karlsson I, Langstrom G (1982) Studies on duration of a late recovery period after chronic abuse of ethanol. A cross-sectional study of biochemical and psychiatric indicators. Acta Psychiatr Scand 66:384–397

    CAS  PubMed  Google Scholar 

  • American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, fourth edition, text revision. American Psychiatric Association, Washington, DC

    Google Scholar 

  • Annis HM, Sklar SM, Moser AE (1998) Gender in relation to relapse crisis situations, coping, and outcome among treated alcoholics. Addict Behav 23:127–131

    CAS  PubMed  Google Scholar 

  • Anton RF, Drobes DJ, Voronin K, Durazo-Avizu R, Moak D (2004a) Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking. Psychopharmacology (Berl) 173:32–40

    CAS  Google Scholar 

  • Anton RF, Moak DH, Latham PK, Waid LR, Malcolm RJ, Dias JK, Roberts JS (2001) Posttreatment results of combining naltrexone with cognitive-behavior therapy for the treatment of alcoholism. J Clin Psychopharmacol 21:72–77

    CAS  PubMed  Google Scholar 

  • Anton RF, Moak DH, Waid LR, Latham PK, Malcolm RJ, Dias JK (1999) Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. AJ Psychiatry 156:1758–1764

    CAS  Google Scholar 

  • Anton RF, O’Malley SS, Ciraulo DA, Cisler RA, Couper D, Donovan DM, Gastfriend DR, Hosking JD, Johnson BA, LoCastro JS, Longabaugh R, Mason BJ, Mattson ME, Miller WR, Pettinati HM, Randall CL, Swift R, Weiss RD, Williams LD, Zweben A (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 295:2003–2017

    CAS  PubMed  Google Scholar 

  • Anton RF, Pettinati H, Zweben A, Kranzler HR, Johnson B, Bohn MJ, McCaul ME, Anthenelli R, Salloum I, Galloway G, Garbutt J, Swift R, Gastfriend D, Kallio A, Karhuvaara S (2004b) A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence. J Clin Psychopharmacol 24:421–428

    CAS  PubMed  Google Scholar 

  • Baker TB, Piper ME, McCarthy DE, Majeskie MR, Fiore MC (2004) Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychol Rev 111:33–51

    PubMed  Google Scholar 

  • Baldwin HA, Hitchcott PK, File SE (1989) Evidence that the increased anxiety detected in the elevated plus-maze during chlordiazepoxide withdrawal is not due to enhanced noradrenergic activity. Pharmacol Biochem Behav 34:931–933

    CAS  PubMed  Google Scholar 

  • Baldwin HA, Rassnick S, Rivier J, Koob GF, Britton KT (1991) CRF antagonist reverses the anxiogenic response to ethanol withdrawal in the rat. Psychopharmacology (Berl) 103:227–232

    CAS  Google Scholar 

  • Balldin J, Berglund M, Borg S, Mansson M, Bendtsen P, Franck J, Gustafsson L, Halldin J, Nilsson LH, Stolt G, Willander A (2003) A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence. Alcohol Clin Exp Res 27:1142–1149

    CAS  PubMed  Google Scholar 

  • Baltieri DA, Daro FR, Ribeiro PL, de Andrade AG (2008) Comparing topiramate with naltrexone in the treatment of alcohol dependence. Addiction 103:2035–2044

    PubMed  Google Scholar 

  • Baltieri DA, De Andrade AG (2004) Acamprosate in alcohol dependence: a randomized controlled efficacy study in a standard clinical setting. J Stud Alcohol 65:136–139

    PubMed  Google Scholar 

  • Barrias J, Chabac S, Ferreira L, Fonte A, Potgieter AS, Teixeira de Sousa E (1997) Acamprosate: multicenter Portuguese efficacy and tolerance evaluation study. Psiquiatria Clinica 18:149–160

    Google Scholar 

  • Begleiter H, Porjesz B (1979) Persistence of a subacute withdrawal syndrome following chronic ethanol intake. Drug Alcohol Depend 4:353–357

    CAS  PubMed  Google Scholar 

  • Berman JD, Cook DM, Buchman M, Keith LD (1990) Diminished adrenocorticotropin response to insulin-induced hypoglycemia in nondepressed, actively drinking male alcoholics. J Clin Endocrinol Metab 71:712–717

    CAS  PubMed  Google Scholar 

  • Bernardy NC, King AC, Parsons OA, Lovallo WR (1996) Altered cortisol response in sober alcoholics: an examination of contributing factors. Alcohol 13:493–498

    CAS  PubMed  Google Scholar 

  • Besson J, Aeby F, Kasas A, Lehert P, Potgieter A (1998) Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: a controlled study. Alcohol Clin Exp Res 22:573–579

    CAS  PubMed  Google Scholar 

  • Betty Ford Institute (2007) What is recovery? A working definition from the Betty Ford Institute. J Subst Abuse Treat 33:221–228

    Google Scholar 

  • Bisaga A, Evans SM (2006) The acute effects of gabapentin in combination with alcohol in heavy drinkers. Drug Alcohol Depend 83(1):25–32

    CAS  PubMed  Google Scholar 

  • Bokstrom K, Balldin J, Langstrom G (1989) Alcohol withdrawal and mood. Acta Psychiatr Scand 80:505–513

    CAS  PubMed  Google Scholar 

  • Bokstrom K, Balldin J, Langstrom G (1991) Individual mood profiles in alcohol withdrawal. Alcohol Clin Exp Res 15:508–513

    CAS  PubMed  Google Scholar 

  • Brady KT, Sonne SC (1999) The role of stress in alcohol use, alcoholism treatment, and relapse. Alcohol Res Health 23:263–271

    CAS  PubMed  Google Scholar 

  • Breese GR, Chu K, Dayas CV, Funk D, Knapp DJ, Koob GF, Le DA, O’Dell LE, Overstreet DH, Roberts AJ, Sinha R, Valdez GR, Weiss F (2005) Stress enhancement of craving during sobriety: a risk for relapse. Alcohol Clin Exp Res 29:185–195

    PubMed Central  PubMed  Google Scholar 

  • Brower KJ, Myra Kim H, Strobbe S, Karam-Hage MA, Consens F, Zucker RA (2008) A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia. Alcohol Clin Exp Res 32:1429–1438

    CAS  PubMed Central  PubMed  Google Scholar 

  • Brown RA, Lejuez CW, Kahler CW, Strong DR (2002) Distress tolerance and duration of past smoking cessation attempts. J Abnorm Psychol 111:180–185

    PubMed  Google Scholar 

  • Carter BL, Tiffany ST (1999) Cue-reactivity and the future of addiction research. Addiction 94:349–351

    CAS  PubMed  Google Scholar 

  • Chick J, Anton R, Checinski K, Croop R, Drummond DC, Farmer R, Labriola D, Marshall J, Moncrieff J, Morgan MY, Peters T, Ritson B (2000a) A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol Alcohol 35:587–593

    CAS  PubMed  Google Scholar 

  • Chick J, Howlett H, Morgan MY, Ritson B (2000b) United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol. Alcohol Alcohol 35:176–187

    CAS  PubMed  Google Scholar 

  • Cleck JN, Blendy JA (2008) Making a bad thing worse: adverse effects of stress on drug addiction. J Clin Invest 118:454–461

    CAS  PubMed Central  PubMed  Google Scholar 

  • Cloninger CR (1987) Neurogenetic adaptive mechanisms in alcoholism. Science 236:410–416

    CAS  PubMed  Google Scholar 

  • Cooney NL, Kadden RM, Litt MD, Getter H (1991) Matching alcoholics to coping skills or interactional therapies: two-year follow-up results. J Consult Clin Psychol 59:598–601

    CAS  PubMed  Google Scholar 

  • Cooney NL, Litt MD, Morse PA, Bauer LO, Gaupp L (1997) Alcohol cue reactivity, negative-mood reactivity, and relapse in treated alcoholic men. J Abnorm Psychol 106:243–250

    CAS  PubMed  Google Scholar 

  • Davidson D, Palfai T, Bird C, Swift R (1999) Effects of naltrexone on alcohol self-administration in heavy drinkers. Alcohol Clin Exp Res 23:195–203

    CAS  PubMed  Google Scholar 

  • Davidson D, Saha C, Scifres S, Fyffe J, O’Connor S, Selzer C (2004) Naltrexone and brief counseling to reduce heavy drinking in hazardous drinkers. Addict Behav 29:1253–1258

    PubMed  Google Scholar 

  • Davidson D, Swift R, Fitz E (1996) Naltrexone increases the latency to drink alcohol in social drinkers. Alcohol Clin Exp Res 20:732–739

    CAS  PubMed  Google Scholar 

  • De Soto CB, O’Donnell WE, Allred LJ, Lopes CE (1985) Symptomatology in alcoholics at various stages of abstinence. Alcohol Clin Exp Res 9:505–512

    PubMed  Google Scholar 

  • de Wit H, Soderpalm AH, Nikolayev L, Young E (2003) Effects of acute social stress on alcohol consumption in healthy subjects. Alcohol Clin Exp Res 27:1270–1277

    PubMed  Google Scholar 

  • de Wit H, Svenson J, York A (1999) Non-specific effect of naltrexone on ethanol consumption in social drinkers. Psychopharmacology (Berl) 146:33–41

    Google Scholar 

  • De Witte P, Pinto E, Ansseau M, Verbanck P (2003) Alcohol and withdrawal: from animal research to clinical issues. Neurosci Biobehav Rev 27:189–197

    PubMed  Google Scholar 

  • Drobes DJ, Anton RF, Thomas SE, Voronin K (2003) A clinical laboratory paradigm for evaluating medication effects on alcohol consumption: naltrexone and nalmefene. Neuropsychopharmacology 28:755–764

    CAS  PubMed  Google Scholar 

  • Ehrenreich H, Schuck J, Stender N, Pilz J, Gefeller O, Schilling L, Poser W, Kaw S (1997) Endocrine and hemodynamic effects of stress versus systemic CRF in alcoholics during early and medium term abstinence. Alcohol Clin Exp Res 21:1285–1293

    CAS  PubMed  Google Scholar 

  • Errico AL, Parsons OA, King AC, Lovallo WR (1993) Attenuated cortisol response to biobehavioral stressors in sober alcoholics. J Stud Alcohol 54:393–398

    CAS  PubMed  Google Scholar 

  • Fox HC, Hong KA, Sinha R (2008) Difficulties in emotion regulation and impulse control in recently abstinent alcoholics compared with social drinkers. Addict Behav 33:388–394

    CAS  PubMed  Google Scholar 

  • Furieri FA, Nakamura-Palacios EM (2007) Gabapentin reduces alcohol consumption and craving: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 68:1691–1700

    CAS  PubMed  Google Scholar 

  • Galloway GP, Koch M, Cello R, Smith DE (2005) Pharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial. BMC Psychiatry 5:18

    PubMed Central  PubMed  Google Scholar 

  • Gastpar M, Bonnet U, Boning J, Mann K, Schmidt LG, Soyka M, Wetterling T, Kielstein V, Labriola D, Croop R (2002) Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study. J Clin Psychopharmacol 22:592–598

    CAS  PubMed  Google Scholar 

  • Geerlings P, Ansoms C, van den Brink W (1997) Acamprosate and prevention of relapse in alcoholics. Eur Addict Res 3:129–137

    Google Scholar 

  • George DT, Herion DW, Jones CL, Phillips MJ, Hersh J, Hill D, Heilig M, Ramchandani VA, Geyer C, Spero DE, Singley ED, O’Malley SS, Bishai R, Rawlings RR, Kunos G (2010) Rimonabant (SR141716) has no effect on alcohol self-administration or endocrine measures in nontreatment-seeking heavy alcohol drinkers. Psychopharmacology (Berl) 208:37–44

    CAS  Google Scholar 

  • Gilman JM, Hommer DW (2008) Modulation of brain response to emotional images by alcohol cues in alcohol-dependent patients. Addict Biol 13:423–434

    PubMed  Google Scholar 

  • Glautier S, Drummond DC (1994) Alcohol dependence and cue reactivity. J Stud Alcohol 55:224–229

    CAS  PubMed  Google Scholar 

  • Gual A, Lehert P (2001) Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain. Alcohol Alcohol 36:413–418

    CAS  PubMed  Google Scholar 

  • Guardia J, Caso C, Arias F, Gual A, Sanahuja J, Ramirez M, Mengual I, Gonzalvo B, Segura L, Trujols J, Casas M (2002) A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial. Alcohol Clin Exp Res 26:1381–1387

    CAS  PubMed  Google Scholar 

  • Hammarberg A, Jayaram-Lindstrom N, Beck O, Franck J, Reid MS (2009) The effects of acamprosate on alcohol-cue reactivity and alcohol priming in dependent patients: a randomized controlled trial. Psychopharmacology (Berl) 205:53–62

    CAS  Google Scholar 

  • Heilig M, Egli M (2006) Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharmacol Ther 111:855–876

    CAS  PubMed  Google Scholar 

  • Heinala P, Alho H, Kiianmaa K, Lonnqvist J, Kuoppasalmi K, Sinclair JD (2001) Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial. J Clin Psychopharmacol 21:287–292

    CAS  PubMed  Google Scholar 

  • Heinz A, Siessmeier T, Wrase J, Buchholz HG, Grunder G, Kumakura Y, Cumming P, Schreckenberger M, Smolka MN, Rosch F, Mann K, Bartenstein P (2005) Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients. Am J Psychiatry 162:1515–1520

    PubMed  Google Scholar 

  • Heinz A, Siessmeier T, Wrase J, Hermann D, Klein S, Grusser S, Flor H, Braus D, Buchholz H, Grunder G, Schrechenberger M, Smolka M, Rosch F, Mann K, Bartenstein P (2004) Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving. Am J Psychiatry 161:1783–1789

    PubMed  Google Scholar 

  • Hershon HI (1977) Alcohol withdrawal symptoms and drinking behavior. J Stud Alcohol 38:953–971

    CAS  PubMed  Google Scholar 

  • Higgins RL, Marlatt GA (1975) Fear of interpersonal evaluation as a determinant of alcohol consumption in male social drinkers. J Abnorm Psychol 84:644–651

    CAS  PubMed  Google Scholar 

  • Higley AE, Crane NA, Spadoni AD, Quello SB, Goodell V, Mason BJ (2011) Craving in response to stress induction in a human laboratory paradigm predicts treatment outcome in alcohol-dependent individuals. Psychopharmacology (Berl) 218:121–129

    CAS  Google Scholar 

  • Holter SM, Engelmann M, Kirschke C, Liebsch G, Landgraf R, Spanagel R (1998) Long-term ethanol self-administration with repeated ethanol deprivation episodes changes ethanol drinking pattern and increases anxiety-related behaviour during ethanol deprivation in rats. Behav Pharmacol 9:41–48

    CAS  PubMed  Google Scholar 

  • Huang MC, Chen CH, Yu JM, Chen CC (2005) A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol dependence in Taiwan. Addict Biol 10:289–292

    CAS  PubMed  Google Scholar 

  • Hull JG, Young RD (1983) Self-consciousness, self-esteem, and success-failure as determinants of alcohol consumption in male social drinkers. J Pers Soc Psychol 44:1097–1109

    CAS  PubMed  Google Scholar 

  • Janiri L, Martinotti G, Dario T, Reina D, Paparello F, Pozzi G, Addolorato G, Di Giannantonio M, De Risio S (2005) Anhedonia and substance-related symptoms in detoxified substance-dependent subjects: a correlation study. Neuropsychobiology 52:37–44

    CAS  PubMed  Google Scholar 

  • Johnson BA, Ait-Daoud N, Akhtar FZ, Ma JZ (2004) Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial. Arch Gen Psychiatry 61:905–912

    CAS  PubMed  Google Scholar 

  • Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K, Javors MA, Ma JZ (2003) Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. Lancet 361:1677–1685

    CAS  PubMed  Google Scholar 

  • Johnson BA, Roache JD, Ait-Daoud N, Zanca NA, Velazquez M (2002) Ondansetron reduces the craving of biologically predisposed alcoholics. Psychopharmacology (Berl) 160:408–413

    CAS  Google Scholar 

  • Johnson BA, Roache JD, Javors MA, DiClemente CC, Cloninger CR, Prihoda TJ, Bordnick PS, Ait-Daoud N, Hensler J (2000) Ondansetron for reduction of drinking among biologically predisposed alcoholic patients: a randomized controlled trial. JAMA 284:963–971

    CAS  PubMed  Google Scholar 

  • Johnson BA, Rosenthal N, Capece JA, Wiegand F, Mao L, Beyers K, McKay A, Ait-Daoud N, Anton RF, Ciraulo DA, Kranzler HR, Mann K, O’Malley SS, Swift RM (2007) Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA 298:1641–1651

    CAS  PubMed  Google Scholar 

  • Junghanns K, Backhaus J, Tietz U, Lange W, Bernzen J, Wetterling T, Rink L, Driessen M (2003) Impaired serum cortisol stress response is a predictor of early relapse. Alcohol Alcohol 38:189–193

    CAS  PubMed  Google Scholar 

  • Junghanns K, Tietz U, Dibbelt L, Kuether M, Jurth R, Ehrenthal D, Blank S, Backhaus J (2005) Attenuated salivary cortisol secretion under cue exposure is associated with early relapse. Alcohol Alcohol 40:80–85

    CAS  PubMed  Google Scholar 

  • Kaplan RF, Meyer RE, Stroebel CF (1983) Alcohol dependence and responsivity to an ethanol stimulus as predictors of alcohol consumption. Br J Addict 78:259–267

    CAS  PubMed  Google Scholar 

  • Kiefer F, Jahn H, Tarnaske T, Helwig H, Briken P, Holzbach R, Kampf P, Stracke R, Baehr M, Naber D, Wiedemann K (2003) Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Arch Gen Psychiatry 60:92–99

    CAS  PubMed  Google Scholar 

  • Killeen TK, Brady KT, Gold PB, Simpson KN, Faldowski RA, Tyson C, Anton RF (2004) Effectiveness of naltrexone in a community treatment program. Alcohol Clin Exp Res 28:1710–1717

    CAS  PubMed  Google Scholar 

  • Koob GF (1998) Circuits, drugs, and drug addiction. Adv Pharmacol 42:978–982

    CAS  PubMed  Google Scholar 

  • Koob GF (2003) Alcoholism: allostasis and beyond. Alcohol Clin Exp Res 27:232–243

    CAS  PubMed  Google Scholar 

  • Koob GF (2006) The neurobiology of addiction: a neuroadaptational view relevant for diagnosis. Addiction 101(1):23–30

    PubMed  Google Scholar 

  • Koob GF (2008) A role for brain stress systems in addiction. Neuron 59:11–34

    CAS  PubMed Central  PubMed  Google Scholar 

  • Koob GF, Ahmed SH, Boutrel B, Chen SA, Kenny PJ, Markou A, O’Dell LE, Parsons LH, Sanna PP (2004) Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev 27:739–749

    CAS  PubMed  Google Scholar 

  • Koob G, Kreek MJ (2007) Stress, dysregulation of drug reward pathways, and the transition to drug dependence. AJ Psychiatry 164:1149–1159

    Google Scholar 

  • Koob GF, Le Moal M (1997) Drug abuse: hedonic homeostatic dysregulation. Science 278:52–58

    CAS  PubMed  Google Scholar 

  • Koob GF, Le Moal M (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24:97–129

    CAS  PubMed  Google Scholar 

  • Koob GF, Le Moal M (2008) Review. Neurobiological mechanisms for opponent motivational processes in addiction. Philos Trans R Soc Lond B Biol Sci 363:3113–3123

    PubMed  Google Scholar 

  • Koob GF, Lloyd GK, Mason BJ (2009) Development of pharmacotherapies for drug addiction: a Rosetta stone approach. Nat Rev Drug Discovery 8:500

    CAS  Google Scholar 

  • Koob GF, Volkow ND (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35:217–238

    PubMed  Google Scholar 

  • Kranzler HR, Armeli S, Tennen H, Blomqvist O, Oncken C, Petry N, Feinn R (2003) Targeted naltrexone for early problem drinkers. J Clin Psychopharmacol 23:294–304

    CAS  PubMed  Google Scholar 

  • Kranzler HR, Modesto-Lowe V, Nuwayser ES (1998) Sustained-release naltrexone for alcoholism treatment: a preliminary study. Alcohol Clin Exp Res 22:1074–1079

    CAS  PubMed  Google Scholar 

  • Kranzler HR, Tennen H, Armeli S, Chan G, Covault J, Arias A, Oncken C (2009) Targeted naltrexone for problem drinkers. J Clin Psychopharmacol 29:350–357

    CAS  PubMed Central  PubMed  Google Scholar 

  • Kranzler HR, Wesson DR, Billot L (2004) Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial. Alcohol Clin Exp Res 28:1051–1059

    CAS  PubMed  Google Scholar 

  • Krystal JH, Cramer JA, Krol WF, Kirk GF, Rosenheck RA (2001) Naltrexone in the treatment of alcohol dependence. N Engl J Med 345:1734–1739

    CAS  PubMed  Google Scholar 

  • Ladewig D, Knecht T, Leher P, Fendl A (1993) Acamprosate—a stabilizing factor in long-term withdrawal of alcoholic patients. Ther Umsch 50:182–188

    CAS  PubMed  Google Scholar 

  • Latt NC, Jurd S, Houseman J, Wutzke SE (2002) Naltrexone in alcohol dependence: a randomised controlled trial of effectiveness in a standard clinical setting. Med J Aust 176:530–534

    PubMed  Google Scholar 

  • Le AD, Harding S, Juzytsch W, Watchus J, Shalev U, Shaham Y (2000) The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology (Berl) 150:317–324

    CAS  Google Scholar 

  • Lhuintre JP, Daoust M, Moore ND, Chretien P, Saligaut C, Tran G, Bosimare F, Hillemand B (1985) Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics. Lancet 1:1014–1016

    CAS  PubMed  Google Scholar 

  • Lindberg L, Brauer S, Wollmer P, Goldberg L, Jones AW, Olsson SG (2007) Breath alcohol concentration determined with a new analyzer using free exhalation predicts almost precisely the arterial blood alcohol concentration. Forensic Sci Int 168:200–207

    CAS  PubMed  Google Scholar 

  • Litt MD, Cooney NL (1999) Inducing craving for alcohol in the laboratory. Alcohol Res Health 23:174–178

    CAS  PubMed  Google Scholar 

  • Litt MD, Cooney NL, Kadden RM, Gaupp L (1990) Reactivity to alcohol cues and induced moods in alcoholics. Addict Behav 15:137–146

    CAS  PubMed  Google Scholar 

  • Litt MD, Cooney NL, Morse P (2000) Reactivity to alcohol-related stimuli in the laboratory and in the field: predictors of craving in treated alcoholics. Addiction 95:889–900

    CAS  PubMed  Google Scholar 

  • Littleton J (1995) Acamprosate in alcohol dependence: how does it work? Addiction 90:1179–1188

    CAS  PubMed  Google Scholar 

  • Liu X, Weiss F (2002) Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J Neurosci 22:7856–7861

    CAS  PubMed  Google Scholar 

  • Lovallo WR, Dickensheets SL, Myers DA, Thomas TL, Nixon SJ (2000) Blunted stress cortisol response in abstinent alcoholic and polysubstance-abusing men. Alcohol Clin Exp Res 24:651–658

    CAS  PubMed  Google Scholar 

  • Macey DJ, Schulteis G, Heinrichs SC, Koob GF (1996) Time-dependent quantifiable withdrawal from ethanol in the rat: effect of method of dependence induction. Alcohol 13:163–170

    CAS  PubMed  Google Scholar 

  • Marlatt G (1985) Situational determinants of relapse and skill-training interventions. In: Marlatt G, Gordan JR (eds) Relapse prevention. Guilford Press, New York, pp 71–127

    Google Scholar 

  • Marlatt GA (1979) A cognitive-behavioral model of the relapse process. NIDA Res Monogr 25:191–200

    Google Scholar 

  • Marlatt GA (1990) Cue exposure and relapse prevention in the treatment of addictive behaviors. Addict Behav 15:395–399

    CAS  PubMed  Google Scholar 

  • Marlatt GA, George WH (1984) Relapse prevention: introduction and overview of the model. Br J Addict 79:261–273

    CAS  PubMed  Google Scholar 

  • Martinez D, Kim JH, Krystal J, Abi-Dargham A (2007) Imaging the neurochemistry of alcohol and substance abuse. Neuroimaging Clin N Am 17:539–555

    Google Scholar 

  • Martinotti G, Cloninger CR, Janiri L (2008a) Temperament and character inventory dimensions and anhedonia in detoxified substance-dependent subjects. Am J Drug Alcohol Abuse 34:177–183

    CAS  PubMed  Google Scholar 

  • Martinotti G, Di Nicola M, Tedeschi D, Andreoli S, Reina D, Pomponi M, Mazza M, Romanelli R, Moroni N, De Filippis R, Di Giannantonio M, Pozzi G, Bria P, Janiri L (2010) Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial. J Psychopharmacol 24(9):1367–1374

    CAS  PubMed  Google Scholar 

  • Martinotti G, Nicola MD, Reina D, Andreoli S, Foca F, Cunniff A, Tonioni F, Bria P, Janiri L (2008b) Alcohol protracted withdrawal syndrome: the role of anhedonia. Subst Use Misuse 43:271–284

    CAS  PubMed  Google Scholar 

  • Mason BJ (2005) Acamprosate in the treatment of alcohol dependence. Expert Opin Pharmacother 6:2103–2115

    CAS  PubMed  Google Scholar 

  • Mason BJ, Goodman AM, Chabac S, Lehert P (2006) Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation. J Psychiatr Res 40:383–393

    PubMed  Google Scholar 

  • Mason BJ, Higley AE, Crane NA, Goodell V (2010) Evaluation of craving and sleep in a human laboratory study of acamprosate, naltrexone and placebo in alcohol dependent volunteers 15th Biennial International Society for Biomedical Research on alcoholism conference. France, Paris

    Google Scholar 

  • Mason BJ, Lehert P (2010) The effects of current subsyndromal psychiatric symptoms or past psychopathology on alcohol dependence treatment outcomes and acamprosate efficacy. Am J Addict 19:147–154

    PubMed  Google Scholar 

  • Mason BJ, Light JM, Escher T, Drobes DJ (2008) Effect of positive and negative affective stimuli and beverage cues on measures of craving in non treatment-seeking alcoholics. Psychopharmacology (Berl) 200:141–150

    CAS  Google Scholar 

  • Mason BJ, Light JM, Williams LD, Drobes DJ (2009) Proof-of-concept human laboratory study for protracted abstinence in alcohol dependence: effects of gabapentin. Addict Biol 14:73–83

    CAS  PubMed Central  PubMed  Google Scholar 

  • Mason BJ, Ritvo EC, Morgan RO, Salvato FR, Goldberg G, Welch B, Mantero-Atienza E (1994) A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence. Alcohol Clin Exp Res 18:1162–1167

    CAS  PubMed  Google Scholar 

  • Mason BJ, Salvato FR, Williams LD, Ritvo EC, Cutler RB (1999) A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence. Arch Gen Psychiatry 56:719–724

    CAS  PubMed  Google Scholar 

  • McCaul ME, Wand GS, Eissenberg T, Rohde CA, Cheskin LJ (2000) Naltrexone alters subjective and psychomotor responses to alcohol in heavy drinking subjects. Neuropsychopharmacology 22:480–492

    CAS  PubMed  Google Scholar 

  • McGeary JE et al (2006) Genetic moderators of naltrexone’s effects on alcohol cue reactivity. Alcohol Clin Exp Res 30(8):1288–1296

    CAS  PubMed  Google Scholar 

  • Miller PM, Hersen M, Eisler RM, Hilsman G (1974) Effects of social stress on operant drinking of alcoholics and social drinkers. Behav Res Ther 12:67–72

    CAS  PubMed  Google Scholar 

  • Miranda R Jr, MacKillop J, Monti PM, Rohsenow DJ, Tidey J, Gwaltney C, Swift R, Ray L, McGeary J (2008) Effects of topiramate on urge to drink and the subjective effects of alcohol: a preliminary laboratory study. Alcohol Clin Exp Res 32:489–497

    CAS  PubMed  Google Scholar 

  • Modesto-Lowe V, Burleson JA, Hersh D, Bauer LO, Kranzler HR (1997) Effects of naltrexone on cue-elicited craving for alcohol and cocaine. Drug Alcohol Depend 49:9–16

    CAS  PubMed  Google Scholar 

  • Moller C, Wiklund L, Thorsell A, Hyytia P, Heilig M (1997) Decreased measures of experimental anxiety in rats bred for high alcohol preference. Alcohol Clin Exp Res 21:656–660

    CAS  PubMed  Google Scholar 

  • Monti PM, Binkoff JA, Abrams DB, Zwick WR, Nirenberg TD, Liepman MR (1987) Reactivity of alcoholics and nonalcoholics to drinking cues. J Abnorm Psychol 96:122–126

    CAS  PubMed  Google Scholar 

  • Monti PM, Rohsenow DJ, Hutchison KE, Swift RM, Mueller TI, Colby SM, Brown RA, Gulliver SB, Gordon A, Abrams DB (1999) Naltrexone’s effect on cue-elicited craving among alcoholics in treatment. Alcohol Clin Exp Res 23:1386–1394

    CAS  PubMed  Google Scholar 

  • Monti PM, Rohsenow DJ, Rubonis AV, Niaura RS, Sirota AD, Colby SM, Abrams DB (1993) Alcohol cue reactivity: effects of detoxification and extended exposure. J Stud Alcohol 54:235–245

    CAS  PubMed  Google Scholar 

  • Morley KC, Teesson M, Reid SC, Sannibale C, Thomson C, Phung N, Weltman M, Bell JR, Richardson K, Haber PS (2006) Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi-centre, randomized, double-blind, placebo-controlled trial. Addiction 101:1451–1462

    PubMed  Google Scholar 

  • Morris PL, Hopwood M, Whelan G, Gardiner J, Drummond E (2001) Naltrexone for alcohol dependence: a randomized controlled trial. Addiction 96:1565–1573

    CAS  PubMed  Google Scholar 

  • Mossberg D, Liljeberg P, Borg S (1985) Clinical conditions in alcoholics during long-term abstinence: a descriptive, longitudinal treatment study. Alcohol 2:551–553

    CAS  PubMed  Google Scholar 

  • Myrick H, Anton R, Voronin K, Wang W, Henderson S (2007) A double-blind evaluation of gabapentin on alcohol effects and drinking in a clinical laboratory paradigm. Alcohol Clin Exp Res 31:221–227

    CAS  PubMed  Google Scholar 

  • Myrick H, Anton RF, Li X, Henderson S, Randall PK, Voronin K (2008) Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people. Arch Gen Psychiatry 65:466–475

    CAS  PubMed Central  PubMed  Google Scholar 

  • Namkoong K, Lee BO, Lee PG, Choi MJ, Lee E (2003) Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study. Alcohol Alcohol 38:135–141

    CAS  PubMed  Google Scholar 

  • Nemeroff CB (1996) The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol Psychiatry 1:336–342

    CAS  PubMed  Google Scholar 

  • Niaura R (2000) Cognitive social learning and related perspectives on drug craving. Addiction 95(Suppl 2): S155–S163

    PubMed  Google Scholar 

  • Niederhofer H, Staffen W (2003) Acamprosate and its efficacy in treating alcohol dependent adolescents. Eur Child Adolesc Psychiatry 12:144–148

    PubMed  Google Scholar 

  • O’Connor AB, Lang VJ (2007) Baclofen not comparable to diazepam for alcohol withdrawal. Am J Med 120: e5; author reply e7

    Google Scholar 

  • O’Farrell TJ, Allen JP, Litten RZ (1995) Disulfiram (antabuse) contracts in treatment of alcoholism. NIDA Res Monogr 150:65–91

    PubMed  Google Scholar 

  • O’Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B (1992) Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry 49:881–887

    PubMed  Google Scholar 

  • O’Malley SS, Krishnan-Sarin S, Farren C, Sinha R, Kreek MJ (2002) Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis. Psychopharmacology (Berl) 160:19–29

    Google Scholar 

  • Ooteman W, Koeter MW, Verheul R, Schippers GM, van den Brink W (2007) The effect of naltrexone and acamprosate on cue-induced craving, autonomic nervous system and neuroendocrine reactions to alcohol-related cues in alcoholics. Eur Neuropsychopharmacol 17:558–566

    CAS  PubMed  Google Scholar 

  • Oslin D, Liberto JG, O’Brien J, Krois S, Norbeck J (1997) Naltrexone as an adjunctive treatment for older patients with alcohol dependence. Am J Geriatr Psychiatry 5:324–332

    CAS  PubMed  Google Scholar 

  • Oslin DW, Lynch KG, Pettinati HM, Kampman KM, Gariti P, Gelfand L, Ten Have T, Wortman S, Dundon W, Dackis C, Volpicelli JR, O’Brien CP (2008) A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention. Alcohol Clin Exp Res 32:1299–1308

    CAS  PubMed  Google Scholar 

  • Overstreet DH, Knapp DJ, Breese GR (2002) Accentuated decrease in social interaction in rats subjected to repeated ethanol withdrawals. Alcohol Clin Exp Res 26:1259–1268

    PubMed Central  PubMed  Google Scholar 

  • Paille FM, Guelfi JD, Perkins AC, Royer RJ, Steru L, Parot P (1995) Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol. Alcohol Alcohol 30:239–247

    CAS  PubMed  Google Scholar 

  • Palfai T, Davidson D, Swift R (1999) Influence of naltrexone on cue-elicited craving among hazardous drinkers: the moderational role of positive outcome expectancies. Exp Clin Psychopharmacol 7:266–273

    CAS  PubMed  Google Scholar 

  • Pelc I, Le Bon O, Verbanck P, Lehert PH, Opsomer L (1992) Calcium-acetylhomotaurinate for maintaining abstinence in weaned alcoholic patients: a placebo-controlled double-blind multi-centre study, in novel pharmacological interventions for alcoholism. In: Naranjo CASE (ed) Novel pharmacological interventions for alcoholism. Springer, New York, pp 348–352

    Google Scholar 

  • Pelc I, Verbanck P, Le Bon O, Gavrilovic M, Lion K, Lehert P (1997) Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients. A 90-day placebo-controlled dose-finding study. Br J Psychiatry 171:73–77

    CAS  PubMed  Google Scholar 

  • Petrakis IL, Poling J, Levinson C, Nich C, Carroll K, Rounsaville B (2005) Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders. Biol Psychiatry 57:1128–1137

    CAS  PubMed  Google Scholar 

  • Pitman RK, Orr SP, Forgue DF, de Jong JB, Claiborn JM (1987) Psychophysiologic assessment of posttraumatic stress disorder imagery in Vietnam combat veterans. Arch Gen Psychiatry 44:970–975

    CAS  PubMed  Google Scholar 

  • Plawecki MH, Decarlo R, Ramchandani VA, O’Connor S (2007) Improved transformation of morphometric measurements for a priori parameter estimation in a physiologically-based pharmacokinetic model of ethanol. Biomed Signal Process Control 2:97–110

    PubMed Central  PubMed  Google Scholar 

  • Plawecki MH, Han JJ, Doerschuk PC, Ramchandani VA, O’Connor SJ (2008) Physiologically based pharmacokinetic (PBPK) models for ethanol. IEEE Trans Biomed Eng 55:2691–2700

    PubMed Central  PubMed  Google Scholar 

  • Poldrugo F (1997) Acamprosate treatment in a long-term community-based alcohol rehabilitation programme. Addiction 92:1537–1546

    CAS  PubMed  Google Scholar 

  • Ramchandani VA, O’Connor S (2006) Studying alcohol elimination using the alcohol clamp method. Alcohol Res Health 29:286–290

    PubMed  Google Scholar 

  • Rasmussen DD, Mitton DR, Green J, Puchalski S (2001) Chronic daily ethanol and withdrawal: 2. Behavioral changes during prolonged abstinence. Alcohol Clin Exp Res 25:999–1005

    CAS  PubMed  Google Scholar 

  • Rassnick S, Heinrichs SC, Britton KT, Koob GF (1993) Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res 605:25–32

    CAS  PubMed  Google Scholar 

  • Ray LA, Hutchison KE (2007) Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study. Arch Gen Psychiatry 64:1069–1077

    CAS  PubMed  Google Scholar 

  • Roberto M, Bajo M, Crawford E, Madamba SG, Siggins GR (2006) Chronic ethanol exposure and protracted abstinence alter NMDA receptors in central amygdala. Neuropsychopharmacology 31:988–996

    CAS  PubMed  Google Scholar 

  • Roelofs SM (1985) Hyperventilation, anxiety, craving for alcohol: a subacute alcohol withdrawal syndrome. Alcohol 2:501–505

    CAS  PubMed  Google Scholar 

  • Roelofs SM, Dikkenberg GM (1987) Hyperventilation and anxiety: alcohol withdrawal symptoms decreasing with prolonged abstinence. Alcohol 4:215–220

    CAS  PubMed  Google Scholar 

  • Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, Colby SM, Kaplan GB (2000) Naltrexone’s effects on reactivity to alcohol cues among alcoholic men. J Abnorm Psychol 109:738–742

    CAS  PubMed  Google Scholar 

  • Rohsenow DJ, Monti PM, Rubonis AV, Sirota AD, Niaura RS, Colby SM, Wunschel SM, Abrams DB (1994) Cue reactivity as a predictor of drinking among male alcoholics. J Consult Clin Psychol 62:620–626

    CAS  PubMed  Google Scholar 

  • Roussaux JP, Hers D, Ferauge M (1996) Does acamprosate diminish the appetite for alcohol in weaned alcoholics? J Pharm Belg 51:65–68

    CAS  PubMed  Google Scholar 

  • Rubonis AV, Colby SM, Monti PM, Rohsenow DJ, Gulliver SB, Sirota AD (1994) Alcohol cue reactivity and mood induction in male and female alcoholics. J Stud Alcohol 55:487–494

    CAS  PubMed  Google Scholar 

  • Sanchis-Segura C, Spanagel R (2006) Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addict Biol 11:2–38

    PubMed  Google Scholar 

  • Sass H, Soyka M, Mann K, Zieglgansberger W (1996) Relapse prevention by acamprosate. Results from a placebo-controlled study on alcohol dependence. Arch Gen Psychiatry 53:673–680

    CAS  PubMed  Google Scholar 

  • Sayette MA, Monti PM, Rohsenow DJ, Gulliver SB, Colby SM, Sirota AD, Niaura R, Abrams DB (1994) The effects of cue exposure on reaction time in male alcoholics. J Stud Alcohol 55:629–633

    CAS  PubMed  Google Scholar 

  • Schuckit MA, Irwin M, Brown SA (1990) The history of anxiety symptoms among 171 primary alcoholics. J Stud Alcohol 51:34–41

    CAS  PubMed  Google Scholar 

  • Segal BM, Kushnarev VM, Urakov IG, Misionzhnik EU (1970) Alcoholism and disruption of the activity of deep cerebral structures. Clinical-laboratory research. Q J Stud Alcohol 31:587–601

    CAS  PubMed  Google Scholar 

  • Sellers EM, Toneatto T, Romach MK, Somer GR, Sobell LC, Sobell MB (1994) Clinical efficacy of the 5-HT3 antagonist ondansetron in alcohol abuse and dependence. Alcohol Clin Exp Res 18:879–885

    CAS  PubMed  Google Scholar 

  • Singleton E, Tiffany S, Henningfield J (1994) Development and validation of a new questionnaire to assess craving for alcohol: problems of drug dependence. In: Proceeding of the 56th annual meeting, The College on Problems of Drug Dependence. National Institute on Drug Abuse, Rockville, MD, p 289

    Google Scholar 

  • Sinha R (2009) Modeling stress and drug craving in the laboratory: implications for addiction treatment development. Addict Biol 14:84–98

    PubMed Central  PubMed  Google Scholar 

  • Sinha R, Fox HC, Hong KA, Bergquist K, Bhagwagar Z, Siedlarz KM (2009) Enhanced negative emotion and alcohol craving, and altered physiological responses following stress and cue exposure in alcohol dependent individuals. Neuropsychopharmacology 34:1198–1208

    CAS  PubMed Central  PubMed  Google Scholar 

  • Sinha R, Fuse T, Aubin LR, O’Malley SS (2000) Psychological stress, drug-related cues and cocaine craving. Psychopharmacology (Berl) 152:140–148

    CAS  Google Scholar 

  • Soyka M, Koller G, Schmidt P, Lesch OM, Leweke M, Fehr C, Gann H, Mann KF (2008) Cannabinoid receptor 1 blocker rimonabant (SR 141716) for treatment of alcohol dependence: results from a placebo-controlled, double-blind trial. J Clin Psychopharmacol 28:317–324

    CAS  PubMed  Google Scholar 

  • Staner L, Boeijinga P, Danel T, Gendre I, Muzet M, Landron F, Luthringer R (2006) Effects of acamprosate on sleep during alcohol withdrawal: a double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects. Alcohol Clin Exp Res 30:1492–1499

    CAS  PubMed  Google Scholar 

  • Swift RM (1999) Medications and alcohol craving. Alcohol Res Health 23:207–213

    CAS  PubMed  Google Scholar 

  • Tempesta E, Janiri L, Bignamini A, Chabac S, Potgieter A (2000) Acamprosate and relapse prevention in the treatment of alcohol dependence: a placebo-controlled study. Alcohol Alcohol 35:202–209

    CAS  PubMed  Google Scholar 

  • Tiffany ST (1999) Cognitive concepts of craving. Alcohol Res Health 23:215–224

    CAS  PubMed  Google Scholar 

  • Uhart M, Wand GS (2009) Stress, alcohol and drug interaction: an update of human research. Addict Biol 14:43–64

    CAS  PubMed Central  PubMed  Google Scholar 

  • Volkow N (2004) Imaging the addicted brain: from molecules to behavior. J Nucl Med 45:13N–24N

    PubMed  Google Scholar 

  • Volpicelli JR, Alterman AI, Hayashida M, O’Brien CP (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876–880

    CAS  PubMed  Google Scholar 

  • Volpicelli JR, Rhines KC, Rhines JS, Volpicelli LA, Alterman AI, O’Brien CP (1997) Naltrexone and alcohol dependence. Role of subject compliance. Arch Gen Psychiatry 54:737–742

    CAS  PubMed  Google Scholar 

  • Voltaire-Carlsson A, Hiltunen AJ, Koechling UM, Borg S (1996) Effects of long-term abstinence on psychological functioning: a prospective longitudinal analysis comparing alcohol-dependent patients and healthy volunteers. Alcohol 13:415–421

    CAS  PubMed  Google Scholar 

  • Vuchinich S, Angelelli J, Gatherum A (1996) Context and development in family problem solving with preadolescent children. Child Dev 67:1276–1288

    CAS  PubMed  Google Scholar 

  • Wand GS, Dobs AS (1991) Alterations in the hypothalamic-pituitary-adrenal axis in actively drinking alcoholics. J Clin Endocrinol Metab 72:1290–1295

    CAS  PubMed  Google Scholar 

  • Watanabe KI, Ogihara-Hashizume A, Kobayashi Y, Mitsushio H, Komiyama T (2001) Impaired sleep during the post-alcohol withdrawal period in alcoholic patients. Addict Biol 6:163–169

    PubMed  Google Scholar 

  • Weinstein A, Feldtkeller B, Feeney A, Lingford-Hughes A, Nutt D (2003) A pilot study on the effects of treatment with acamprosate on craving for alcohol in alcohol-dependent patients. Addict Biol 8:229–232

    CAS  PubMed  Google Scholar 

  • Whitworth AB, Fischer F, Lesch OM, Nimmerrichter A, Oberbauer H, Platz T, Potgieter A, Walter H, Fleischhacker WW (1996) Comparison of acamprosate and placebo in long-term treatment of alcohol dependence. Lancet 347:1438–1442

    CAS  PubMed  Google Scholar 

  • Zimmermann US, Mick I, Vitvitskyi V, Plawecki MH, Mann KF, O’Connor S (2008) Development and pilot validation of computer-assisted self-infusion of ethanol (CASE): a new method to study alcohol self-administration in humans. Alcohol Clin Exp Res 32:1321–1328

    PubMed  Google Scholar 

  • Zorrilla EP, Valdez GR, Weiss F (2001) Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology (Berl) 158:374–381

    CAS  Google Scholar 

Download references

Acknowledgments

Preparation of this review was supported by NIAAA grant numbers RO1AA12602 and R37AA014028 to BJM and the Pearson Center for Alcoholism and Addiction Research.

Author information

Authors and Affiliations

  1. Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA, 92037, USA

    Barbara J. Mason & Amanda E. Higley

  2. The Pearson Center for Alcoholism and Addiction Research, Laboratory of Clinical Psychopharmacology, The Scripps Research Institute, 10550 North Torrey Pines Road, TPC-5, La Jolla, CA, 92037, USA

    Barbara J. Mason

Authors
  1. Barbara J. Mason
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amanda E. Higley
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Barbara J. Mason .

Editor information

Editors and Affiliations

  1. Abt. Psychopharmakologie, Zentralinstitut für Seelische Gesundheit, J 5, Mannheim, 68159, Germany

    Wolfgang H. Sommer

  2. Abt. Psychopharmakologie, Zentralinstitut für Seelische Gesundheit, J 5, Mannheim, 68159, Germany

    Rainer Spanagel

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Mason, B.J., Higley, A.E. (2012). A Translational Approach to Novel Medication Development for Protracted Abstinence. In: Sommer, W., Spanagel, R. (eds) Behavioral Neurobiology of Alcohol Addiction. Current Topics in Behavioral Neurosciences, vol 13. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-28720-6_201

Download citation

Publish with us

Policies and ethics

Search

Navigation